Authors:
Haicheur, N
Escudier, B
Dorval, T
Negrier, S
De Mulder, PHM
Dupuy, JM
Novick, D
Guillot, T
Wolf, S
Pouillart, P
Fridman, WH
Tartour, E
Citation: N. Haicheur et al., Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients, CLIN EXP IM, 119(1), 2000, pp. 28-37
Authors:
Tartour, E
Mehtali, M
Sastre-Garau, X
Joyeux, I
Mathiot, C
Pleau, J
Squiban, P
Rochlitz, C
Courtney, M
Jantscheff, P
Herrmann, R
Pouillart, P
Fridman, WH
Dorval, T
Citation: E. Tartour et al., Phase I clinical trial with IL-2-transfected xenogeneic cells administeredin subcutaneous metastatic tumours: clinical and immunological findings, BR J CANC, 83(11), 2000, pp. 1454-1461
Authors:
Rochlitz, C
Jantscheff, P
Bongartz, G
Dietrich, PY
Quiquerez, AL
Schatz, C
Mehtali, M
Courtney, M
Tartour, E
Dorval, T
Fridman, WH
Herrmann, R
Citation: C. Rochlitz et al., Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors, CANC GENE T, 6(3), 1999, pp. 271-281
Authors:
Cochet, O
Martin, E
Fridman, WH
Teillaud, JL
Citation: O. Cochet et al., Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived V kappa by PNA-mediated PCR clamping, BIOTECHNIQU, 26(5), 1999, pp. 818
Authors:
Cochet, O
Gruel, N
Fridman, WH
Teillaud, JL
Citation: O. Cochet et al., Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: A novel approach for cancer therapy?, CANCER DET, 23(6), 1999, pp. 506-510
Authors:
Boyer, A
Andreu, G
Romet-Lemonne, JL
Fridman, WH
Teillaud, JL
Citation: A. Boyer et al., Generation of phagocytic MAK and MAC-DC for therapeutic use: Characterization and in vitro functional properties, EXP HEMATOL, 27(4), 1999, pp. 751-761
Authors:
Rouard, H
Tamasdan, S
Fridman, WH
Teillaud, JL
Citation: H. Rouard et al., Vav and SLP-76 recruitment by cross-linking of Fc gamma RIIa1 in promyelocytic HL-60 cells, IMMUNOL LET, 68(2-3), 1999, pp. 347-353
Authors:
Moldovan, I
Galon, J
Maridonneau-Parini, I
Roman, SR
Mathiot, C
Fridman, WH
Sautes-Fridman, C
Citation: I. Moldovan et al., Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions, IMMUNOL LET, 68(1), 1999, pp. 125-134
Authors:
Kotlan, B
Gruel, N
Zafrani, B
Furedi, G
Foldi, J
Petranyi, GG
Fridman, WH
Teillaud, JL
Citation: B. Kotlan et al., Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma, IMMUNOL LET, 65(3), 1999, pp. 143-151
Authors:
Bruhns, P
Marchetti, P
Fridman, WH
Vivier, E
Daeron, M
Citation: P. Bruhns et al., Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors, J IMMUNOL, 162(6), 1999, pp. 3168-3175
Authors:
Gey, A
Hamdi, S
Vielh, P
Mehtali, M
Fridman, WH
Tartour, E
Citation: A. Gey et al., Development of a direct in situ RT-PCR method using labeled primers to detect cytokine mRNA inside cells, J IMMUNOL M, 227(1-2), 1999, pp. 149-160
Authors:
Lienard, H
Bruhns, P
Malbec, O
Fridman, WH
Daeron, M
Citation: H. Lienard et al., Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation, J BIOL CHEM, 274(45), 1999, pp. 32493-32499
Authors:
Pages, F
Berger, A
Henglein, B
Piqueras, B
Danel, C
Zinzindohoue, F
Thiounn, N
Cugnenc, PH
Fridman, WH
Citation: F. Pages et al., Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance, INT J CANC, 84(3), 1999, pp. 326-330
Authors:
Tartour, E
Fossiez, F
Joyeux, I
Galinha, A
Gey, A
Claret, E
Sastre-Garau, X
Couturier, J
Mosseri, V
Vives, V
Banchereau, J
Fridman, WH
Wijdenes, J
Lebecque, S
Sautes-Fridman, C
Citation: E. Tartour et al., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, CANCER RES, 59(15), 1999, pp. 3698-3704